e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Different expression of CD44variant6 in BAL mesenchymal cells is related to BOS severity
Emanuela Cova (Pavia, Italy), Michele Zorzetto, Laura Pandolfi, Simona Inghilleri, Laura Dovizia, Monica Morosini, Angelo Corsico, Davide Piloni, Giulia Stella, Federica Meloni, Emanuela Cova
Source:
International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Session:
Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Session type:
Poster Discussion
Number:
1794
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Emanuela Cova (Pavia, Italy), Michele Zorzetto, Laura Pandolfi, Simona Inghilleri, Laura Dovizia, Monica Morosini, Angelo Corsico, Davide Piloni, Giulia Stella, Federica Meloni, Emanuela Cova. Different expression of CD44variant6 in BAL mesenchymal cells is related to BOS severity. Eur Respir J 2015; 46: Suppl. 59, 1794
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The impact of anti-IgE treatment on the airway microbiome in asthma.
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Effusions related to TB
Related content which might interest you:
Aberrant metalloprotease expression and activity in bronchoalveolar lavage fluid of bronchiolitis obliterans patients
Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction
Year: 2013
Cytologicalfeaturesof bronchoalveolar lavage in different variants of exogenous allergic alveolitis
Source: International Congress 2014 – ILDs 5
Year: 2014
Inflammatory markers in serum and lavage fluid in young adult’s patients with postinfectious bronchiolitis obliterans
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013
Characterization of inflammation in bronchoalveolar lavage of lung transplant patients
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Bronchoalveolar lavage fluid leukotrienes in the pathomechanism of acute inflammatory events in lung transplant recipients
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Comparison between Bronchoalveolar Lavage (BAL) and blood-derived microvesicles in lung diseases
Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair
Year: 2021
Profile of airway mucins in bronchoalveolar lavage fluid of patients with pulmonary alveolar proteinosis
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Expression of matrix metalloproteinases in bronchoalveolar cells in COPD and in COPD phenotypes
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Optimizing a protocol for the NMR-based metabolic profiling of BALf in bronchiolitis obliterans syndrome
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016
The use of bronchoalveolar lavage (BAL) to assess lower airways inflammation in asthma
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
HNP and CCSP protein levels are differentially regulated in BAL from patients with obstructive and restrictive chronic allograft dysfunctions
Source: International Congress 2015 – Predictors of lung transplant complications
Year: 2015
Microparticles as biomarkers of lung injury in human broncho-alveolar lavage fluid
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014
Periostin in lower airway samples and serum, a novel asthma marker?
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Differences in the lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) in lung transplanted patients
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016
Serum and bronchoalveolar exosomal miRNAs in pulmonary sarcoidosis
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015
Investigation of mitochondria homeostasis and mitophagy in bronchoalveolar lavage fluid (BALF) cells in pulmonary fibrosis
Source: International Congress 2015 – IPF pathogenesis
Year: 2015
Influence of systemic steroid treatment on bronchoalveolar (BAL) cytological composition and cell cycle in selected interstitial lung diseases
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
Bronchoalveolar lavage: how can we use it more effectively to define pathology?
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006
Effects of infections on lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) after lung transplantation
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept